Patent Information
- (54) Name
- USE OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND DOXORUBICINE FOR TREATING NON-HODGKIN' S LYMPHOMAS
- (21) Filing number
- PT34055
- (21) EP Number
- 2268310 (open in ep register)
- (51) Classification
- N/A
- Supplementary Protection
- N/A
- (22) Application date
- 15/12/2016
- (24) Registration date
- 21/04/2017
- Expiry date
- 23/03/2027 Renew
- Status
- Registered
- Protection period
- 18
Priority Details
N/A
Applicant Details
| (731) Name / Company | Address | State | Town | Post code | Country |
|---|---|---|---|---|---|
| Roche Glycart AG | Wagistrasse 18 | Schlieren-Zuerich | 8952 | Switzerland |
Inventor Details
N/A
Representative Details
| (731) Name / Company | Address | State | Town | Post code | Country |
|---|---|---|---|---|---|
| Saba & Co IP CYPRUS | P.O. Box 21143 | Nicosia | 1502 | Cyprus |
All Documents
N/A